-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
In Vitro Killing Experiment Platform of InnoModels Biotechnology
Author:
InnoModels
Release time:
2024-10-09
In the field of life sciences, in vitro killing experimental platform is gradually becoming an important tool for drug development and cell research. Among them, the in vitro killing experimental platform of InnoModels Biotechnology has attracted the attention of many researchers with its unique technical advantages and wide application prospects. In this paper, we will introduce in detail the features and advantages of InnoModels' in vitro killing platform and its applications in scientific research.
Overview of InnoModels Biocidal Experimental Platform
As a biotech company co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Champion and Shanghai Jiao Tong University Institute of Immunology, InnoModels Biotechnology (Beijing) Co., Ltd. is noteworthy for its innovative practices in the field of life sciences. The company not only owns a stable domestic platform for humanized mouse models of the immune system (HIS) and a platform for human-derived tumor xenografts (PDX), but also devotes itself to building an efficient and precise platform for in vitro killing experiments, which can provide powerful support for the research and development of new drugs and cellular mechanisms.
Platform Features
1、Highly controllable experimental environment: InnoModels' in vitro killing experimental platform provides the ability to precisely control the experimental conditions, such as temperature, humidity, and atmosphere, to ensure the accuracy and reproducibility of the experimental results. This highly controllable environment provides researchers with a stable and reliable experimental platform, allowing cell killing experiments to be conducted under optimal conditions.
2、 Support for multiple cell types: The platform supports the application of multiple cell types, including tumor cells, primary cells, etc., which meets the diverse needs of researchers in different fields.
This flexibility enables researchers to carry out in-depth cell killing experiments in a wide range of fields and promote the progress of scientific research.
3、Real-time monitoring and data analysis: During the experimental process, the platform is able to monitor the cell status and response in real time, and at the same time record and analyze the data.
This real-time feedback mechanism provides researchers with comprehensive experimental results, helping them to more accurately understand the cell killing mechanism and drug action effects.
4、Automation technology application: Thermo Scientific's in vitro cell-killing experimental platform adopts advanced automation technology, which significantly improves the efficiency of the experimental process and reduces the errors caused by human operation.
The application of this technology not only improves the reliability of experiments, but also allows researchers to focus more on experimental design and data analysis.

Application Areas
1、 drug screening: researchers can use the platform for large-scale drug screening to assess the killing effect of drugs on cells.
This helps to rapidly screen drug candidates with potential therapeutic effects, providing strong support for drug development.
2、Toxicity assessment: The platform can also be used to assess the toxicity level of compounds or drugs, providing important data for safety assessment during drug development.
This is important to ensure the safety of drugs in clinical trials.
3、Immunotherapy research: In the study of immunotherapy, the platform can be used to assess the killing effect of immune cells on tumor cells.
This assessment helps to gain a deeper understanding of the mechanisms and effects of immunotherapy, providing a scientific basis for clinical application.
Conclusion
With its unique technical advantages and wide application prospects, the InnoModels Bioin vitro killing experimental platform shows great potential in the field of life sciences. The platform not only provides researchers with efficient and precise experimental tools, but also promotes the in-depth development of drug development and cell mechanism research. In the future, with the continuous progress of the technology and the expansion of the application, InnoModels in vitro killing experimental platform will certainly play an even more important role in the field of life sciences.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd